IJD

6-cyclopropyl-N-{1-[2-(dimethylamino)ethyl]-3-(pyridin-2-yl)-1H-pyrazol-5-yl}-3-[(pyrimidin-5-yl)amino]pyridine-2-carboxamide

Created:	2022-01-26
Last modified:	2022-10-12

Find Related PDB Entry
1 entries where IJD is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	62
Chiral Atom Count	0
Bond Count	66
Aromatic Bond Count	23

2D diagram of IJD

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	6-cyclopropyl-N-{1-[2-(dimethylamino)ethyl]-3-(pyridin-2-yl)-1H-pyrazol-5-yl}-3-[(pyrimidin-5-yl)amino]pyridine-2-carboxamide
Systematic Name (OpenEye OEToolkits)	6-cyclopropyl-~{N}-[2-[2-(dimethylamino)ethyl]-5-pyridin-2-yl-pyrazol-3-yl]-3-(pyrimidin-5-ylamino)pyridine-2-carboxamide
Formula	C₂₅ H₂₇ N₉ O
Molecular Weight	469.542
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	CN(C)CCn1nc(cc1NC(=O)c1nc(ccc1Nc1cncnc1)C1CC1)c1ccccn1
SMILES	CACTVS	3.385	CN(C)CCn1nc(cc1NC(=O)c2nc(ccc2Nc3cncnc3)C4CC4)c5ccccn5
SMILES	OpenEye OEToolkits	2.0.7	CN(C)CCn1c(cc(n1)c2ccccn2)NC(=O)c3c(ccc(n3)C4CC4)Nc5cncnc5
Canonical SMILES	CACTVS	3.385	CN(C)CCn1nc(cc1NC(=O)c2nc(ccc2Nc3cncnc3)C4CC4)c5ccccn5
Canonical SMILES	OpenEye OEToolkits	2.0.7	CN(C)CCn1c(cc(n1)c2ccccn2)NC(=O)c3c(ccc(n3)C4CC4)Nc5cncnc5
InChI	InChI	1.03	InChI=1S/C25H27N9O/c1-33(2)11-12-34-23(13-22(32-34)20-5-3-4-10-28-20)31-25(35)24-21(29-18-14-26-16-27-15-18)9-8-19(30-24)17-6-7-17/h3-5,8-10,13-17,29H,6-7,11-12H2,1-2H3,(H,31,35)
InChIKey	InChI	1.03	YQBHCXNSRTWRPM-UHFFFAOYSA-N

Related Resource References

Resource Name	Reference
Pharos	CHEMBL3639410
PubChem	53328445
ChEMBL	CHEMBL3639410

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.